Smith Group Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Smith Group Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,160	Closed	-$112K	–	417
2019 Q3	$112K	Buy	+1,160	New	+$116K	﹤0.01%	235
2019 Q1	–	Sell	-3,740	Closed	-$146K	–	483
2018 Q4	$146K	Sell	3,740 -210	-5%	-$9.11K	0.01%	267
2018 Q3	$215K	Buy	3,950 +1,120	+40%	+$76.6K	0.01%	247
2018 Q2	$234K	Hold	2,830	–	–	0.01%	242
2018 Q1	$188K	Sell	2,830 -2,300	-45%	-$133K	0.01%	258
2017 Q4	$264K	Hold	5,130	–	–	0.01%	236
2017 Q3	$457K	Buy	+5,130	New	+$390K	0.02%	221

Smith Group Asset Management's ONCE Position: Q4 2019 in Review

Smith Group Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 1,160 shares — an estimated $112K sold.

Smith Group Asset Management first reported a position in ONCE in Q3 2017 and held it in 7 quarters. The position peaked at $457K in Q3 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Smith Group Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Smith Group Asset Management sold 1,160 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $112K.
Smith Group Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2017 and held it in 7 quarters.
Smith Group Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $457K in Q3 2017.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Smith Group Asset Management's 13F filing for Q4 2019, filed 4 Feb 2020.